The interplay of reactive oxygen species, hypoxia, inflammation, and sirtuins in cancer initiation and progression

M Tafani, L Sansone, F Limana… - Oxidative medicine …, 2016 - Wiley Online Library
The presence of ROS is a constant feature in living cells metabolizing O2. ROS
concentration and compartmentation determine their physiological or pathological effects …

Chemoprevention of cancer

AS Tsao, ES Kim, WK Hong - CA: a cancer journal for clinicians, 2004 - Wiley Online Library
Cancer chemoprevention is defined as the use of natural, synthetic, or biologic chemical
agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer. The …

Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity

CM Remsberg, JA Yáñez, Y Ohgami… - … Journal Devoted to …, 2008 - Wiley Online Library
The present study evaluated the preclinical pharmacokinetics and pharmacodynamics of
trans‐pterostilbene, a constituent of some plants. Right jugular vein cannulated male …

[Retracted] The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis

Y Bie, W Ge, Z Yang, X Cheng, Z Zhao, S Li… - Disease …, 2019 - Wiley Online Library
CXCL8 (also known as IL‐8) can produce different biological effects by binding to its
receptors: CXCR1, CXCR2, and the Duffy antigen receptor for chemokines (DARC). CXCL8 …

[HTML][HTML] Rationale and means to target pro-inflammatory interleukin-8 (CXCL8) signaling in cancer

LM Campbell, PJ Maxwell, DJJ Waugh - Pharmaceuticals, 2013 - mdpi.com
It is well established that chronic inflammation underpins the development of a number of
human cancers, with pro-inflammatory signaling within the tumor microenvironment …

5 Selective inhibitors of cyclooxygenase-2 (COT-2)

JJ Talley - Progress in medicinal chemistry, 1999 - Elsevier
Publisher Summary This chapter focuses on selective inhibitors of cyclooxygenase-2 (COX-
2). Two distinct COX enzymes were recently identified (i) a constitutive form (COX-1) present …

Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection

J Rüschoff, S Wallinger, W Dietmaier… - Proceedings of the …, 1998 - National Acad Sciences
Nonsteroidal anti-inflammatory drugs (NSAIDs) are well-known cancer preventives, which
have been largely attributed to their antiproliferative and apoptosis-inducing activities. In this …

Adverse effects of nonsteroidal anti-inflammatory drugs on the gastrointestinal system

E Fosslien - Annals of Clinical & Laboratory Science, 1998 - Assoc Clin Scientists
Two enzymes, cyclo-oxygenase (COX) and 5-lipoxygenase, act upon arachidonic acids to
produce prostaglandins and leukotrienes. Inhibition of COX-2 by non-steroidal anti …

[HTML][HTML] Modulators of HIF1α and NFkB in cancer treatment: is it a rational approach for controlling malignant progression?

M Tafani, B Pucci, A Russo, L Schito… - Frontiers in …, 2013 - frontiersin.org
HIF1α and NFkB are two transcription factors very frequently activated in tumors and
involved in tumor growth, progression, and resistance to chemotherapy. In fact, HIF1α and …

Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma

AW Bak, W McKnight, P Li, P Del Soldato, A Calignano… - Life Sciences, 1998 - Elsevier
Aspirin decreases the risk of colorectal cancer, reportedly through suppression of
cyclooxygenase (COX) activity. Using a rat model of colonic adenocarcinoma, we compared …